Retinoic acid reduces the cytotoxicity of cyclopentenyl cytosine in neuroblastoma cells

FEBS Letters

Volumn 527, Issue 1-3, 2002, Pages 229-233

  Bierau, Jörgen ^a   Van Gennip, Albert H ^a   Leen, René ^a   Caron, Huib N ^b   Van Kuilenburg, André B P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Cyclopentenyl cytosine; Cytosine 5 triphosphate synthetase; Neuroblastoma; Pyrimidine de novo metabolism; Pyrimidine salvage metabolism; Retinoic acid

Indexed keywords

1 (4,5 DIHYDROXY 3 HYDROXYMETHYL 2 CYCLOPENTEN 1 YL)CYTOSINE; CASPASE 3; CYTIDINE TRIPHOSPHATE; CYTIDINE TRIPHOSPHATE SYNTHASE; RETINOIC ACID; UNCLASSIFIED DRUG; URIDINE;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL STRAIN; CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; CYTIDINE; CYTIDINE TRIPHOSPHATE; DRUG INTERACTIONS; HUMANS; NEUROBLASTOMA; POLYPHOSPHATES; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0037063313     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(02)03234-9     Document Type: Article

References (33)

1. Evans A.E., D'Angio G.J., Sather H.N., de Lorimier A.A., Dalton A., Ungerleider R.S., Finklestein J.Z., Hammond G.D. J. Clin. Oncol. 8:1990;678-688.
2. Yamamoto K., Hanada R., Kikuchi A., Ichikawa M., Aihara T., Oguma E., Moritani T., Shimanuki Y., Tanimura M., Hayashi Y. J. Clin. Oncol. 16:1998;1265-1269.
3. Haas D., Ablin A.R., Miller C., Zoger S., Matthay K.K. Cancer. 62:1988;818-825.
4. Lovat P.E., Irving H., Annicchiarico-Petruzzelli M., Bernassola F., Malcolm A.J., Pearson A.D., Melino G., Redfern C.P. J. Natl. Cancer Inst. 89:1997;446-452.
5. Abemayor E. Laryngoscope. 102:1992;1133-1149.
6. Adamson P.C., Reaman G., Finklestein J.Z., Feusner J., Berg S.L., Blaney S.M., O'Brien M., Murphy R.F., Balis F.M. J. Clin. Oncol. 15:1997;3330-3337.
7. Smith M.A., Adamson P.C., Balis F.M., Feusner J., Aronson L., Murphy R.F., Horowitz M.E., Reaman G., Hammond G.D., Fenton R.M. J. Clin. Oncol. 10:1992;1666-1673.
8. Khan A.A., Villablanca J.G., Reynolds C.P., Avramis V.I. Cancer Chemother. Pharmacol. 39:1996;34-41.
9. Villablanca J.G., Khan A.A., Avramis V.I., Seeger R.C., Matthay K.K., Ramsay N.K., Reynolds C.P. J. Clin. Oncol. 13:1995;894-901.
10. Kohler J.A., Imeson J., Ellershaw C., Lie S.O. Br. J. Cancer. 83:2000;1124-1127.
11. Kogner P., Barbany G., Persson H., Soderhall S., Ahstrom L., Bjork O. Prog. Clin. Biol. Res. 385:1994;147-153.
12. Lovat P.E., Irving H., Malcolm A.J., Pearson A.D., Redfern C.P. J. Neurooncol. 31:1997;85-91.
13. Han G., Chang B., Connor M.J., Sidell N. Differentiation. 59:1995;61-69.
14. Lovat P.E., Irving H., Annicchiarico-Petruzzelli M., Bernassola F., Malcolm A.J., Pearson A.D., Melino G., Redfern C.P. Eur. J. Cancer. 33:1997;2075-2080.
15. Urbach J., Rando R.R. Biochem. J. 299:(Pt 2):1994;459-465.
16. Lansink M., van Bennekum A.M., Blaner W.S., Kooistra T. Eur. J. Biochem. 247:1997;596-604.
17. Venditti A., Stasi R., Del Poeta G., Buccisano F., Aronica G., Bruno A., Pisani F., Caravita T., Masi M., Tribalto M., Domenica Simone M., Avvisati G., Amadori S., Papa G. Leukemia. 9:1995;1121-1125.
18. Tallman M.S., Andersen J.W., Schiffer C.A., Appelbaum F.R., Feusner J.H., Ogden A., Shepherd L., Rowe J.M., Francois C., Larson R.S., Wiernik P.H. Blood. 95:2000;90-95.
19. Hassan H.T., Rees J.K. Chemotherapy. 36:1990;51-57.
20. Kang G.J., Cooney D.A., Moyer J.D., Kelley J.A., Kim H.Y., Marquez V.E., Johns D.G. J. Biol. Chem. 264:1989;713-718.
21. Bierau J., Van Gennip A.H., Helleman J., Van Kuilenburg A.B.P. Biochem. Pharmacol. 62:2001;1099-1105.
22. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Cancer Res. 47:1987;936-942.
23. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Anal. Biochem. 150:1985;76-85.
24. Van Kuilenburg A.B.P., Elzinga L., Verschuur A.C., van den Berg A.A., Slingerland R.J., Van Gennip A.H. J. Chromatogr. B Biomed. Sci. Appl. 693:1997;287-295.
25. Fairbanks L.D., Bofill M., Ruckemann K., Simmonds H.A. J. Biol. Chem. 270:1995;29682-29689.
26. Jones K.W., Rylett R.J., Hammond J.R. Brain Res. 660:1994;104-112.
27. Zhang H., Cooney D.A., Zhang M.H., Ahluwalia G., Ford H. Jr., Johns D.G. Cancer Res. 53:1993;5714-5720.
28. Maehara Y., Kusumoto T., Sakaguchi Y., Kusumoto H., Kido Y., Anai H., Sugimachi K. Cancer. 63:1989;96-101.
29. Slingerland, R.J., Van Gennip, A.H., Bodlaender, J.M., Heijink, L., Voute, P.A. and Van Kuilenburg, A.B.P. (1996) Ribonucleotide Metabolism of Neural Crest Derived Cancer Cells, PhD thesis, University of Amsterdam, Amsterdam.
30. Lombet A., Zujovic V., Kandouz M., Billardon C., Carvajal-Gonzalez S., Gompell A., Rostene W. Eur. J. Biochem. 268:2001;1352-1362.
31. Lasorella A., Iavarone A., Israel M.A. Cancer Res. 55:1995;4711-4716.
32. Kim C.J., Kim H.O., Choe Y.J., Lee Y.A., Kim C.W. Anticancer Res. 15:1995;1997-2000.
33. Ronca F., Yee K.S., Yu V.C. J. Biol. Chem. 274:1999;18128-18134.